Trial reportLeukemia2009
A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response.
Trial report in Leukemia, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- CD34International journal of hematology · 2022Article
- The vascular bone marrow niche influences outcome in chronic myeloid leukemiaHaematologica · 2020Article
- Article
- Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells.Oncogene · 2014Article
- Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond.Hematology. American Society of Hematology. Education Program · 2013Review
- Curing chronic myeloid leukemia.Current hematologic malignancy reports · 2012Review
- Therapy of chronic myeloid leukaemia can benefit from the activation of stem cells: simulation studies of different treatment combinations.British journal of cancer · 2012Article
- Role of STAT3 in Transformation and Drug Resistance in CML.Frontiers in oncology · 2012Article
- Stem cell quiescence.Clinical cancer research : an official journal of the American Association for Cancer Research · 2011Review
- Article
- The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues.Haematologica · 2011Review
- Targeting leukemic stem cells by breaking their dormancy.Molecular oncology · 2010Review
- Review
- Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis.Haematologica · 2010Article
- Awakening dormant haematopoietic stem cells.Nature reviews. Immunology · 2010Article
- Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues.Leukemia · 2009Review
- Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib.PLoS computational biology · 2009Article
- New experimental and theoretical investigations of hematopoietic stem cells and chronic myeloid leukemia.Blood cells, molecules & diseasesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
19262595What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.